Skip to Main Content

Vaccines

The latest stories related to vaccines, including development and production issues.

Latest

Letters to the editor Patrick Skerrett

Letters on Sonya Massey’s death, vaccine injuries, and much more

Special Report Andrew Joseph

4 takeaways from STAT’s story on the development of malaria vaccines

Special Report Andrew Joseph

Behind the malaria vaccines: A 40-year quest against one of humanity’s biggest killers

Health Helen Branswell

Bird flu snapshot: Upstart manufacturers in low- and middle-income countries to start early vaccine work

Health Elizabeth Cooney

Vaccination slashes risk of long Covid, says large study tracing cases through Delta and Omicron variants

First Opinion Podcast Patrick Skerrett

Listen: Empathy should be the first response to people with vaccine injury, fears

Pharma Adam Feuerstein

STAT Plus: GSK buys mRNA-based Covid, flu vaccines from CureVac in restructured partnership

Health Helen Branswell

Moderna receives $176 million from BARDA for mRNA influenza vaccines

All Coverage

Health Rohan Rajeev

On the road to eliminate rabies deaths, Gavi announces plan to improve human vaccination

The Readout Adam Feuerstein

STAT Plus: A biotech’s binary bet ends badly

advertisement

The Readout Meghana Keshavan

STAT Plus: FDA offers new guidelines for Covid-19 vaccine

Letters to the editor Patrick Skerrett

Readers respond to a plea for rare disease progress, vaccine-related injury, and more

First Opinion Julie Sweetland

Telling new stories can help people see the value of vaccines

First Opinion Kizzmekia S. Corbett-Helaire

Empathy should guide responses to reported vaccine injuries

The Readout Meghana Keshavan

The biotech news you missed from the weekend

Health Helen Branswell

STAT Plus: FDA expands approval for GSK’s RSV vaccine to cover younger at-risk adults

The Readout Elaine Chen

Novavax will be able to supply Covid-19 vaccines this fall

First Opinion Tom Daschle and Kathleen G. Sebelius

Close a regulatory loophole in the ACA to provide vaccine access for all Americans

The Readout Jason Mast

STAT Plus: Testing begins for a new form of PrEP

The Readout Meghana Keshavan

STAT Plus: Can AstraZeneca make good on its promise?

Biotech Helen Branswell

STAT Plus: FDA approves Moderna’s RSV vaccine, its second licensed product

The Readout Elaine Chen

STAT Plus: In light of H5N1 outbreak, U.S. in talks with mRNA vaccine makers on bird flu

The Readout Elaine Chen

STAT Plus: Maryland takes first steps to cap drug costs

Health Helen Branswell

When should we start making H5N1 vaccine, and who will make that decision? In short, it’s complicated

In the Lab Annalisa Merelli and Jonathan Wosen

Animal studies lend support to an innovative HIV vaccine strategy — but there’s still a long way to go

The Readout Meghana Keshavan

AstraZeneca antibody reduced Covid-19 risk in immunocompromised

First Opinion Phyllis Arthur

A dose of reality on adult vaccinations

Biotech Andrew Joseph

STAT Plus: Sanofi enters vaccine licensing deal with Novavax, giving beleaguered biotech a lifeline

Health Annalisa Merelli

A new cholera vaccine will increase supply, but will it be enough to manage global outbreaks?